XML 53 R42.htm IDEA: XBRL DOCUMENT v3.20.2
FAIR VALUE MEASUREMENT (Details) - USD ($)
$ in Thousands
Sep. 30, 2020
Dec. 31, 2019
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents Fair Value Disclosure $ 566 $ 2,799
Equity Securities, FV-NI 455 823
Marketable Securities 1,355 10,308
Debt Securities, Trading, and Equity Securities, FV-NI 121 116
Assets, Fair Value Disclosure 2,497 14,046
Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent 138 116
Financial and Nonfinancial Liabilities, Fair Value Disclosure 138 116
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents Fair Value Disclosure 566 2,799
Equity Securities, FV-NI 455 823
Marketable Securities 1,355 10,308
Debt Securities, Trading, and Equity Securities, FV-NI 121 116
Assets, Fair Value Disclosure 2,497 14,046
Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent 138 116
Financial and Nonfinancial Liabilities, Fair Value Disclosure 138 116
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents Fair Value Disclosure 0 0
Equity Securities, FV-NI 0 0
Marketable Securities 0 0
Debt Securities, Trading, and Equity Securities, FV-NI 0 0
Assets, Fair Value Disclosure 0 0
Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent 0 0
Financial and Nonfinancial Liabilities, Fair Value Disclosure 0 0
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Cash Equivalents Fair Value Disclosure 0 0
Equity Securities, FV-NI 0 0
Marketable Securities 0 0
Debt Securities, Trading, and Equity Securities, FV-NI 0 0
Assets, Fair Value Disclosure 0 0
Deferred Compensation Cash-based Arrangements, Liability, Current and Noncurrent 0 0
Financial and Nonfinancial Liabilities, Fair Value Disclosure $ 0 $ 0